Open original FDA record ↗Recall record
- FDA identifier
- Z-1141-2024
- Company in FDA record
- HeartSine Technologies Ltd
- FDA classification date
- Feb 15, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Automated external defibrillators were shipped in their test configuration so there is a potential to have incorrect language, and CPR duration resulting in the device prompting users to perform CPR for 5-seconds, and it could analyze heart rhythm and instruct users to deliver a shock every 5-seconds if a shockable heart rhythm is detected, potentially leading to no therapy or delayed therapy.
Source facts
- Action
- On 2/14/24, correction notices were mailed to customers who were asked to do the following: 1) Maintain awareness of this communication internally until the required action has been completed within your facility. 2) Inform the recalling firm if any of the subject devices were distributed to other organizations. The firm will work with you to ensure recipients are notified appropriately. 3) Complete and return the acknowledgment form to RSRecall@Stryker.com Upon receipt of the acknowledgment form, the firm will provide instructions on next steps including device replacement. If you have any questions or concerns, please contact the firm's Customer Support at +44 28 9093 9400, 9:00 A.M. to 5:00 P.M. (GMT), Monday - Friday or by email at heartsinesupport@stryker.com.
- Initiated
- 2024-02-14
- Root cause
- Process control
- Distribution
- Worldwide - US Nationwide distribution in the states of TX, CA, IL, CO, FL, NC, MI and the countries of Netherlands, Japan, New Zealand.
- Recall number
- Z-1141-2024
- Recall status
- Open, Classified
- CDRH record ID
- 206009
- FDA classified
- 2024-02-15
- Recall event number
- 93962